And a recent study found that in a mouse model, mTOR activation combined with p38MAPK-p53 / p16 axis inactivation can trigger renal cell carcinoma like that in humans, suggesting an important role in tumorigenesis (63). The gene discussed is TP53; the disease is renal cell carcinoma.